MyHealthChecked PLC Notice of Results (8141W)
August 23 2022 - 2:00AM
UK Regulatory
TIDMMHC
RNS Number : 8141W
MyHealthChecked PLC
23 August 2022
MyHealthChecked PLC
( " MyHealthChecked " or the "Company " )
Notice of Results
Investor Presentation
MyHealthChecked plc (AIM: MHC), the consumer home-testing
healthcare company, will announce its Half-year Report for the six
months ended 30 June 2022 on Wednesday 21 September 2022.
Investor presentation
Penny McCormick, Chief Executive Officer and Nicholas Edwards,
Chief Financial Officer will provide a live presentation relating
to the Half-year Report via the Investor Meet Company platform on
Thursday 22 September 2022 at 4:30pm BST.
The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via the Investor
Meet Company dashboard up until 9:00am BST the day before the
meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add
to meet MyHealthChecked plc via:
https://www.investormeetcompany.com/myhealthchecked-plc/register-investor
Investors who already follow MyHealthChecked Plc on the Investor
Meet Company platform will automatically be invited.
For further information contact:
MyHealthChecked plc www.myhealthchecked.com
P enny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Oberon Capital Ltd (Broker) Tel: +44 (0)20 3179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Anna Dunphy Mob: +44(0)7876 741 001
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA
and RNA tests that have been developed following the acquisition of
The Genome Store in November 2020. The tests are available online,
and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORBXGDIIXDDGDD
(END) Dow Jones Newswires
August 23, 2022 02:00 ET (06:00 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Jan 2024 to Jan 2025